Patients With and Without Phonotrauma

ConditionPhonotrauma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-65
SponsorUniversity of Texas Southwestern Medical Center

About this trial

There is a substantial need to identify objective measures associated with hyperadduction of the vocal folds to recognize those at higher risk of developing phonotrauma so that risk mitigation strategies can be implemented before phonotrauma develops. The overall objective of this proposed project is to investigate the sensitivity and direction of change in cepstral peak prominence (CPP) and the magnitude difference between the first two harmonics of the voice spectrum (H1-H2) in response to varied phonation patterns, which will be addressed using the following two aims:

Aim 1: Determine how CPP and H1-H2 change as a function of using pressed voice production in individuals without laryngeal pathology.

Aim 2: Examine the sensitivity (minimally detectable change) and responsiveness (minimal clinically important difference) of CPP and H1-H2 to detect changes in different voice production conditions.

Eligibility criteria

Qualifiers

18-65 years of age (to avoid confounding physiological factors related to puberty or presbyphonia)

No history of or current voice disorder

Auditory perceptual presentation globally within functional limits (as determined by a voice specialized SLP).

Disqualifiers

Atypical auditory-perceptual voice presentation

History of voice disorder or laryngeal surgery.

Diagnosed with phonotrauma (i.e., vocal fold nodules, vocal fold polyp, vocal fold pseudocyst, mid-fold edema) by a laryngologist.

18-65 years of age

Trial design

Treatments tested in this trial

  • Acoustic voice analysis
  • High-speed videoendoscopy

Treatment groups

100 Participants
are divided into 2 treatment groups